Special article: Future directions in malignant hyperthermia research and patient care
Sharon J Hirshey Dirksen1, Marilyn Green Larach, Henry Rosenberg
1MHAUS, 1 North Main St, PO Box 1069, Sherburne, NY 13460, USA. sharon@mhaus.org
Abstract:
Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
Related Concept Videos
Increased Body Temperature
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Skeletal Muscle Relaxants: Therapeutic Uses
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


